FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W117366895> ?p ?o ?g. }

• W117366895 endingPage "71" @default.
• W117366895 startingPage "64" @default.
• W117366895 abstract "This study sought to assess the 2-year outcomes of the population included in the EXAMINATION (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction) trial beyond the 1-year prescription period of dual antiplatelet therapy.The EXAMINATION trial compared the performance of everolimus-eluting stents (EES) versus bare-metal stents (BMS) in an all-comer ST-segment elevation myocardial infarction (STEMI) population.This was a multicenter, multinational, prospective, randomized, single-blind, controlled trial in patients with STEMI. The primary endpoint, which was the combined endpoint of all-cause death, any recurrent myocardial infarction, and any revascularization, and the endpoints target lesion revascularization and stent thrombosis were assessed at 2 years.Between December 31, 2008, and May 15, 2010, 1,498 patients were randomized to receive EES (n = 751) or BMS (n = 747). Compliance with dual antiplatelet regimen was reduced at 2 years to a similar degree (17.3% vs. 17.2%, p = 0.91). At 2 years, the primary endpoint occurred in 108 (14.4%) patients of the EES group and in 129 (17.3%) patients of the BMS group (p = 0.11). Rate of target lesion revascularization was significantly lower in the EES group than in the BMS group (2.9% vs. 5.6%; p = 0.009). Rates of definite and definite or probable stent thrombosis were also significantly reduced in the EES group (0.8% vs. 2.1%; p = 0.03, and 1.3% vs. 2.8%; p = 0.04, respectively).The 2-year follow-up of the EXAMINATION trial confirms the safety and efficacy of the EES compared with BMS in the setting of STEMI. Specifically, both rates of target lesion revascularization and stent thrombosis were reduced in recipients of EES without any signs of late attrition for either of these endpoints. (A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction: EXAMINATION Study; NCT00828087)." @default.
• W117366895 created "2016-06-24" @default.
• W117366895 creator A5004072409 @default.
• W117366895 creator A5010111405 @default.
• W117366895 creator A5011133072 @default.
• W117366895 creator A5011188783 @default.
• W117366895 creator A5015944413 @default.
• W117366895 creator A5029245765 @default.
• W117366895 creator A5032028897 @default.
• W117366895 creator A5035239568 @default.
• W117366895 creator A5035688682 @default.
• W117366895 creator A5059249712 @default.
• W117366895 creator A5063792624 @default.
• W117366895 creator A5074704083 @default.
• W117366895 creator A5079151837 @default.
• W117366895 creator A5091304840 @default.
• W117366895 date "2014-01-01" @default.
• W117366895 modified "2023-10-18" @default.
• W117366895 title "The EXAMINATION Trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction)" @default.
• W117366895 cites W104440196 @default.
• W117366895 cites W1409723433 @default.
• W117366895 cites W149951570 @default.
• W117366895 cites W1737944821 @default.
• W117366895 cites W1921048136 @default.
• W117366895 cites W1964129959 @default.
• W117366895 cites W1996637683 @default.
• W117366895 cites W1999124647 @default.
• W117366895 cites W2029603191 @default.
• W117366895 cites W2029986831 @default.
• W117366895 cites W2046209971 @default.
• W117366895 cites W2057218988 @default.
• W117366895 cites W2087150869 @default.
• W117366895 cites W2102968559 @default.
• W117366895 cites W2103766009 @default.
• W117366895 cites W2105332661 @default.
• W117366895 cites W2106499407 @default.
• W117366895 cites W2106820552 @default.
• W117366895 cites W2109100788 @default.
• W117366895 cites W2112494872 @default.
• W117366895 cites W2114531853 @default.
• W117366895 cites W2121754217 @default.
• W117366895 cites W2124385743 @default.
• W117366895 cites W2125716797 @default.
• W117366895 cites W2133272102 @default.
• W117366895 cites W2135505698 @default.
• W117366895 cites W2135880473 @default.
• W117366895 cites W2141165366 @default.
• W117366895 cites W2141196495 @default.
• W117366895 cites W2146743728 @default.
• W117366895 cites W2147673265 @default.
• W117366895 cites W2151468302 @default.
• W117366895 cites W2161108007 @default.
• W117366895 cites W2161895979 @default.
• W117366895 cites W2163606238 @default.
• W117366895 cites W4205193932 @default.
• W117366895 doi "https://doi.org/10.1016/j.jcin.2013.09.006" @default.
• W117366895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24332423" @default.
• W117366895 hasPublicationYear "2014" @default.
• W117366895 type Work @default.
• W117366895 sameAs 117366895 @default.
• W117366895 citedByCount "78" @default.
• W117366895 countsByYear W1173668952014 @default.
• W117366895 countsByYear W1173668952015 @default.
• W117366895 countsByYear W1173668952016 @default.
• W117366895 countsByYear W1173668952017 @default.
• W117366895 countsByYear W1173668952018 @default.
• W117366895 countsByYear W1173668952019 @default.
• W117366895 countsByYear W1173668952020 @default.
• W117366895 countsByYear W1173668952021 @default.
• W117366895 countsByYear W1173668952022 @default.
• W117366895 countsByYear W1173668952023 @default.
• W117366895 crossrefType "journal-article" @default.
• W117366895 hasAuthorship W117366895A5004072409 @default.
• W117366895 hasAuthorship W117366895A5010111405 @default.
• W117366895 hasAuthorship W117366895A5011133072 @default.
• W117366895 hasAuthorship W117366895A5011188783 @default.
• W117366895 hasAuthorship W117366895A5015944413 @default.
• W117366895 hasAuthorship W117366895A5029245765 @default.
• W117366895 hasAuthorship W117366895A5032028897 @default.
• W117366895 hasAuthorship W117366895A5035239568 @default.
• W117366895 hasAuthorship W117366895A5035688682 @default.
• W117366895 hasAuthorship W117366895A5059249712 @default.
• W117366895 hasAuthorship W117366895A5063792624 @default.
• W117366895 hasAuthorship W117366895A5074704083 @default.
• W117366895 hasAuthorship W117366895A5079151837 @default.
• W117366895 hasAuthorship W117366895A5091304840 @default.
• W117366895 hasBestOaLocation W1173668951 @default.
• W117366895 hasConcept C126322002 @default.
• W117366895 hasConcept C141071460 @default.
• W117366895 hasConcept C164705383 @default.
• W117366895 hasConcept C168563851 @default.
• W117366895 hasConcept C203092338 @default.
• W117366895 hasConcept C2778583881 @default.
• W117366895 hasConcept C2779464278 @default.
• W117366895 hasConcept C2779699572 @default.
• W117366895 hasConcept C2908647359 @default.
• W117366895 hasConcept C500558357 @default.
• W117366895 hasConcept C71924100 @default.

• next